PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER

NIH RePORTER · NIH · N02 · $296,637 · view on reporter.nih.gov ↗

Abstract

The contractor will conduct a pre-surgical pilot study to evaluate the effect of daily exemestane on proliferation of endometrial tissue in post-menopausal women diagnosed with complex atypical hyperplasia/endometrial intraepithelial neoplasia or Grade 1 endometrial cancer.

Key facts

NIH application ID: 10674471
Project number: 261201200033I-P00008-26100011-1
Recipient: UNIVERSITY OF WISCONSIN-MADISON
Principal Investigator: HOWARD BAILEY
Activity code: N02
Funding institute: NIH
Fiscal year: 2022
Award amount: $296,637
Award type: —
Project period: 2017-09-15 → 2023-03-31